Japan Amifostine Market Geographic Scope, Industry Chain, Forecast by 2025

Overview Of Amifostine Industry 2021-2025:

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The Amifostine Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.

Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.

In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

Amifostine Market competition by top manufacturers as follow: Clinigen Group, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma, Mingren Pharma,

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/268052

The global Amifostine market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

The Type Coverage in the Market are: 400mg/Dose
500mg/Dose

Market Segment by Applications, covers:
Head and Neck Cancer Adjuvant Therapy
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Major factors covered in the report:

• Global Amifostine Market summary
• Economic Impact on the Industry
• Market Competition in terms of Manufacturers
• Production, Revenue (Value) by geographical segmentation
• Production, Revenue (Value), Price Trend by Type
• Market Analysis by Application
• Cost Investigation
• Industrial Chain, Raw material sourcing strategy and Downstream Buyers
• Marketing Strategy comprehension, Distributors and Traders
• Study on Market Research Factors
• Global Amifostine Market Forecast

To get this report at a profitable rate.: https://reportsinsights.com/discount/268052

The analysis objectives of the report are:

• To know the Global Amifostine Market size by pinpointing its sub-segments.
• To study the important players and analyse their growth plans.
• To analyse the amount and value of the Global AmifostineMarket, depending on key regions
• To analyse the Global Amifostine Market concerning growth trends, prospects and also their participation in the entire sector.
• To examine the Global Amifostine Market size (volume & value) from the company, essential regions/countries, products and application, background information.
• Primary worldwide Global Amifostine Market manufacturing companies, to specify, clarify and analyse the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans for future.
• To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

Our report offers:

– Market share assessments for the regional and country level segments.
– Market share analysis of the top industry players.
– Strategic recommendations for the new entrants.
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets.
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations).
– Strategic recommendations in key business segments based on the market estimations.
– Competitive landscaping mapping the key common trends.
– Company profiling with detailed strategies, financials, and recent developments.
– Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Amifostine-Market-268052

About US:

ReportsInsights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

Email: info@reportsinsights.com

Sales: sales@reportsinsights.com